Climb Bio, Inc. (NASDAQ:CLYM – Get Free Report) Director Stephen Basil Thomas sold 100,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 15th. The shares were sold at an average price of $13.67, for a total value of $1,367,000.00. Following the completion of the sale, the director directly owned 467,969 […]

Acacia Research Corporation (NASDAQ:ACTG – Get Free Report) Director Isaac Kohlberg sold 24,000 shares of the company’s stock in a transaction on Tuesday, September 15th. The stock was sold at an average price of $4.55, for a total transaction of $109,200.00. Following the transaction, the director owned 54,310 shares in the company, valued at approximately […]

Carlyle Group Inc. (NASDAQ:CG – Get Free Report) Director David Rubenstein sold 400,000 shares of Carlyle Group stock in a transaction that occurred on Friday, September 11th. The stock was sold at an average price of $42.74, for a total transaction of $17,096,000.00. Following the completion of the sale, the director owned 26,899,644 shares of […]

Interface, Inc. (NASDAQ:TILE – Get Free Report) Director Daniel Hendrix sold 8,000 shares of Interface stock in a transaction that occurred on Wednesday, September 2nd. The stock was sold at an average price of $37.13, for a total value of $297,040.00. Following the completion of the transaction, the director owned 88,147 shares of the company’s […]